SEC Comment Letter for KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — Jul 17, 2013
KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: July 17, 2013 · CIK: 0001075880 · Accession: 0000000000-13-039040
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-29962
Letter
July 17, 201 3 Via E -mail Graham Kelly Chief Executive Officer Novogen Limited 1-7 Waterloo Road, Level 1 North Ryde, New South Wales 2113 Australia
Re: Novogen Limited Form 20-F for the Fiscal Year Ended June 30, 201 2 Filed Octob er 29, 201 2 File No. 000-29962
Dear Dr. Kelly :
We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy a nd adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Joel Parker
Show Raw Text
July 17, 201 3 Via E -mail Graham Kelly Chief Executive Officer Novogen Limited 1-7 Waterloo Road, Level 1 North Ryde, New South Wales 2113 Australia Re: Novogen Limited Form 20-F for the Fiscal Year Ended June 30, 201 2 Filed Octob er 29, 201 2 File No. 000-29962 Dear Dr. Kelly : We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy a nd adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Joel Parker Joel Parker Accounting Branch Chief